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DOI: http://dx.doi.org/10.1016/j.hemonc.2013.05.009A44-year-old Moroccan man had sudden on-set of speech disturbance, vertiginous sensa-tion, confusion, emesis, and altered mental
status. There was no history of fever, trauma, or
any major systemic illness. His general and systemic
examination was unremarkable. On neurological
examination, the patient was oriented to time, place
and person. There were no disturbances of higher
function nor were meningeal signs observed. An
examination of the cranial nerves showed no abnor-
malities. The levels of blood glucose, electrolytes, cal-
cium, phosphorus, and lactic dehydrogenase were
normal, as were the results of renal and liver function
tests. Computed tomography of the brain revealed a
homogenous mass in the corpus callosum which mea-
sured approximately 3.5 cm, appearing slightly hyper-
dense to gray matter (Panel A), and strongly
enhanced after the intravenous administration of con-
trast material. One satellite nodule was found in the
left frontal lobe. Magnetic resonance imaging of the
brain showed a hypointense lesion on T1 imaging thatPanel A.
Hematowas hyperintense on T2 and FLAIR images, and en-
hanced after contrast administration (Panels B and
C). These radiological ﬁndings strongly suggested that
the CNS lesions were malignant lymphoma. Stereo-
tactic biopsy was performed. Histological examinationPanel B.
Panel C.
l Oncol Stem Cell Ther 6(3–4) Fourth Quarter 2013 hemoncstem.edmgr.com
CORPUS CALLOSUM LYMPHOMA images and diagnosis
of the specimens revealed diffuse proliferation of lym-
phoma which were positive for CD20 and CD79a,
and negative for CD3. A diagnosis of de novo diffuse
large B-cell lymphoma was made. Appropriate inves-
tigations were performed to stage the lymphoma.
Bone marrow biopsy, abdominal ultrasonography,
thoracic and abdominal CT scans did not reveal any
systemic lesions. Cerebrospinal ﬂuid examination
was normal. Serology for human immunodeﬁciency
virus was negative. The patient was started on and re-Hematol Oncol Stem Cell Ther 6(3–4) Fourth Quarter 2013 hemoncstem.edmgr.sponded well to chemotherapy consisting of metho-
trexate, vincristine, procarbazine and intrathecal
methotrexate (Memorial Sloan-Kettering Cancer
Center protocol).CONFLICT OF INTEREST
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